Stansberry Venture Technology editor Dave Lashmet joins the show to talk all things biotech – why he looks bottom up at companies, the three phases of drug testing, and the supply problems with weight-loss drugs. Plus, Dan and Corey discuss the political motivations behind the Federal Reserve potentially cutting rates this year.
Subscribe for FREE. Get the Stansberry Investor Hour podcast delivered straight to your inbox.